Journals / İnfeksiyon Dergisi / 2006 / Cilt: 20 - Sayı: 4

Interactions of Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis

Kistik fibrozizde Pseudomonas aeruginosa ve Burkholderia cepacia arasındaki etkileşimler

Pages
287–293
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, interactions of P. aeruginosa and B. cepacia in CF is reviewed based on the recent literature, focusing on microbial pathogenesis, bacterial infections, CF isolates, cellto- cell communication and biofilm formations in the CF lung.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Gram-negative bacteria Pseudomonas aeruginosa and Burkholderia cepacia are opportunistic human pathogens that are responsible for severe nosocomial infections in immunocompromised patients and are the major pathogens in cystic fibrosis (CF).
📊
Key Findings & Data:The two bacteria not only inhabit the same environmental niches but can also form mixed biofilms in the lungs of CF patients.
💡
Conclusion & Impact:In this article, interactions of P. aeruginosa and B. cepacia in CF is reviewed based on the recent literature, focusing on microbial pathogenesis, bacterial infections, CF isolates, cellto- cell communication and biofilm formations in the CF lung.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The Gram-negative bacteria Pseudomonas aeruginosa and Burkholderia cepacia are opportunistic human pathogens that are responsible for severe nosocomial infections in immunocompromised patients and are the major pathogens in cystic fibrosis (CF). The two bacteria not only inhabit the same environmental niches but can also form mixed biofilms in the lungs of CF patients. Hence, it appears very likely that the two organisms are capable of interacting with each other, there is a synergism for pathogenesis and frequent exchange of genetic material between the two organisms. In this article, interactions of P. aeruginosa and B. cepacia in CF is reviewed based on the recent literature, focusing on microbial pathogenesis, bacterial infections, CF isolates, cellto- cell communication and biofilm formations in the CF lung.

Özet

Gram-negatif bakteriler olan Pseudomonas aeruginosa ve Burkholderia cepacia bağışık baskılı hastalarda çeşitli nozokom'iyal infeksiyonlardan sorumlu fırsatçı insan patojenleri olup kistik fıbrozis (KF)'deki başlıca patojenlerdir. Bu iki bakteri sadece doğada benzer yerlerde yayılım göstermekle kalmaz aynı zamanda KF'li hastaların ciğerlerindeki karışık biyofilmlerin oluşumuna da neden olurlar. Böylelikle, iki organizmanın birbiriyle etkileşim içerisinde olduğu, aralarında patogenez açısından sinerjik bir ilişki olduğu ve aralarında sıklıkla genetik materyal aktarımı bulunduğu kesindir. Bu makalede, KF'deki P. aeruginosa ve S. cepacia etkileşimleri; mikrobiyal patogenez, bakteri infeksiyonları, KF izolatları, hücreler arası iletişim-sinyalleşme, KF'li akciğerdeki biyofilm oluşumları konularına odaklanılarak yeniden ele alınmıştır.

🔖

Cite This Article

ÖZDEMİR, G., CEYHAN, N. (2022). Interactions of Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis. İnfeksiyon Dergisi, Cilt: 20 - Sayı: 4, 287–293. https://ajindex.com/articles/546437

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Tsui LC. The cystic fibrosis transmembrane conductance regulator gene. Am J Respir Crit Care Med 1995; 151: 47-53
  2. Tuğ E, Tuğ T. Kistik fibrozis ve moleküler-genetik yaklaşımlar. Toraks Dergisi 2003; 4:198-204
  3. Özçelik U. Kistik fibrozis akciğer hastalığında patogenez. Çocuk Sağlığı ve Hastalıkları Dergisi 2004; 47: 299-302
  4. Tümmler B, Kiewitz C. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections. Mol Med Today 1999; 5: 351-8
  5. Ratjen F, Döring G. Cystic fibrosis. Lancet 2003; 361: 681 -9
  6. Dinwiddie R. Pathogenesis of lung disease in cystic fibrosis. Respiration 2000; 67: 3-8
  7. Smith A. Pathogenesis of bacterial bronchitis in cystic fibrosis. Pediatr Infect Dis J1997; 16: 91-6
  8. Conese M, Assael BM. Bacterial infections and inflammation in the lungs of cystic fibrosis patients. Pediatr Infect Dis J 2001; 20: 207-13
  9. Govan JRW, Deretic V. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996; 60: 539-74
  10. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991; 4: 35-51
  11. May TB, Shinabarger D, Maharaj R, et al. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev 1991; 4: 191-206
  12. Fegan M, Francis P, Hayward AC, Fuerst JA. Heterogenecity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients. J Clin Microbiol 1991; 29: 2151 -7
  13. Şener B. Kistik fibrozisde mikrobiyal patogenez. Hacettepe Tıp Dergisi 2002; 33: 49 - 57
  14. Şener B, Köseoğlu Ö, Özçelik U, Kocagöz T, Günalp A. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. Int J Med Microbiol 2001; 291: 387-93
  15. Lyczak JB, Cannon CL, Pier GB, Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002; 15: 194-222
  16. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004: 17, 57-71
  17. Hodson ME. Bacterial infection in cystic fibrosis (CF): Special reference to Mycobacteria and Burkholderia cepacia. Pediatric Pulmonology 1995; 11:(Suppl):66-7
  18. De KievitTR. Iglewski BH. Bacterial quorum sensing in pathogenic relationships. Infect Immun 2000.68: 4839-49.19. Camara M, Williams P, Hardman A. Controlling infection by tuning in and turning down the volume of bacterial small-talk. Lancet Infect Dis 2002; 2: 667-76
  19. Latifi A,